CX NEWS
Podium 1st: New developments in fusion imaging – artificial intelligence that deforms anatomy to maintain accuracy
Recorded presentation from CX Symposium 2019 Bijan Modarai, London, United Kingdom
Podium 1st: Potential EVAS cardiovascular mortality benefit through active sac management when compared to EVAR
Recorded presentation from CX Symposium 2019 Marc Schermerhorn, Boston, United States
Breaking news from CX 2019: Cook leads the way to data transparency with release of long-term ZILVER PTX patient-level data
There were several calls at the CX 2019 Highlight Session Paclitaxel: The last word on the need for a meta-analysis of individual patient-level data going forward and greater transparency and sharing of the available [...]
Key take-aways from the CX 2019 Highlight Session on Paclitaxel: The Last Word
Elena Ladich (Hollywood, USA) and Roger Greenhalgh (London, UK) discuss the current uncertainty surrounding the use of paclitaxel devices and the need for individual patient-level data analyses going forward to better understand the mortality [...]
While CX audience deems paclitaxel not dangerous, vascular pathologist says establishing “truth takes time”
Elena Ladich Delegates voted overwhelmingly against the notion that there was a demonstrable danger in any organ of the body attributed to circulating paclitaxel. These polling results, with a 67% majority, came [...]
CX highlights Acute Stroke Challenges
On Monday, the 2019 Charing Cross (CX) Symposium opened with the Acute Stroke Challenges programme; the session, which was chaired by Barbara Rantner (Innsbruck, Austria), Hugh Markus (Cambridge, UK) and Ross Naylor (Leicester, UK), [...]